Substituted benzimidazoles as kinase inhibitors

Details for Australian Patent Application No. 2006287688 (hide)

Owner Novartis AG

Inventors Pick, Teresa E.; Ramurthy, Savithri; Levine, Barry Haskell; Dove, Jeffrey H.; Stuart, Darrin; Shafer, Cynthia; Amiri, Payman; Poon, Daniel J.; Renhowe, Paul A.; Aikawa, Mina E.; Subramanian, Sharadha; McBride, Christopher

Agent Davies Collison Cave

Pub. Number AU-B-2006287688

PCT Pub. Number WO2007/030377

Priority 60/712,539 30.08.05 US; 60/713,108 30.08.05 US; 60/774,684 17.02.06 US; 60/731,591 27.10.05 US

Filing date 30 August 2006

Wipo publication date 15 March 2007

Acceptance publication date 19 August 2010

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/030377 Priority application(s): WO2007/030377

19 August 2010 Application Accepted

  Published as AU-B-2006287688

16 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006287693-Liquid rheological additive suitable for thickening solvent borne, pigmentcontaining systems

2006287678-Method for treating subcutaneous tissues